Free Trial

Surgery Partners (SGRY) Competitors

Surgery Partners logo
$23.08 +0.65 (+2.90%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$22.93 -0.15 (-0.65%)
As of 05/2/2025 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SGRY vs. HIMS, GH, OPCH, RDNT, SHC, WGS, BTSG, PRVA, CON, and LFST

Should you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.

Surgery Partners vs.

Surgery Partners (NASDAQ:SGRY) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

Hims & Hers Health has a net margin of 8.19% compared to Surgery Partners' net margin of -2.03%. Hims & Hers Health's return on equity of 10.97% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.03% 2.85% 1.22%
Hims & Hers Health 8.19%10.97%8.29%

Surgery Partners currently has a consensus target price of $34.75, suggesting a potential upside of 50.56%. Hims & Hers Health has a consensus target price of $36.92, suggesting a potential downside of 9.92%. Given Surgery Partners' stronger consensus rating and higher probable upside, equities analysts plainly believe Surgery Partners is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08

63.5% of Hims & Hers Health shares are held by institutional investors. 2.3% of Surgery Partners shares are held by insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Surgery Partners has higher revenue and earnings than Hims & Hers Health. Surgery Partners is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.11B0.95-$11.90M-$1.33-17.35
Hims & Hers Health$1.48B6.17-$23.55M$0.5475.89

Surgery Partners received 271 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 57.83% of users gave Surgery Partners an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Surgery PartnersOutperform Votes
314
57.83%
Underperform Votes
229
42.17%
Hims & Hers HealthOutperform Votes
43
35.25%
Underperform Votes
79
64.75%

In the previous week, Hims & Hers Health had 54 more articles in the media than Surgery Partners. MarketBeat recorded 58 mentions for Hims & Hers Health and 4 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.74 beat Hims & Hers Health's score of 0.68 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Hims & Hers Health
26 Very Positive mention(s)
8 Positive mention(s)
14 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

Surgery Partners has a beta of 2.4, suggesting that its share price is 140% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.

Summary

Surgery Partners and Hims & Hers Health tied by winning 9 of the 18 factors compared between the two stocks.

Get Surgery Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGRY vs. The Competition

MetricSurgery PartnersGeneral medical & surgical hospitals IndustryMedical SectorNASDAQ Exchange
Market Cap$2.95B$12.95B$5.56B$8.04B
Dividend YieldN/A0.66%5.09%4.22%
P/E Ratio-48.085.5122.6818.83
Price / Sales0.950.57404.28106.72
Price / Cash14.306.8638.1834.62
Price / Book0.9632.376.794.33
Net Income-$11.90M$1.20B$3.22B$247.97M
7 Day Performance7.45%5.95%2.44%2.71%
1 Month Performance-1.95%-0.35%3.78%3.37%
1 Year Performance-7.68%7.54%17.05%5.80%

Surgery Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGRY
Surgery Partners
3.2925 of 5 stars
$23.08
+2.9%
$34.75
+50.6%
-7.7%$2.95B$3.11B-48.0812,200Upcoming Earnings
News Coverage
Positive News
HIMS
Hims & Hers Health
2.4139 of 5 stars
$28.51
+1.5%
$38.08
+33.6%
+234.5%$6.33B$1.48B64.80650Upcoming Earnings
Analyst Forecast
Insider Trade
Options Volume
News Coverage
High Trading Volume
GH
Guardant Health
4.5381 of 5 stars
$47.99
-0.6%
$49.00
+2.1%
+152.2%$5.92B$739.02M-13.481,790Earnings Report
Analyst Forecast
News Coverage
Positive News
Gap Up
OPCH
Option Care Health
3.188 of 5 stars
$32.97
+0.2%
$33.75
+2.4%
+10.2%$5.42B$5.00B27.715,600Earnings Report
Analyst Upgrade
Analyst Revision
News Coverage
Positive News
RDNT
RadNet
4.0649 of 5 stars
$51.03
+1.5%
$69.75
+36.7%
+3.3%$3.78B$1.83B-728.908,970Upcoming Earnings
Positive News
SHC
Sotera Health
1.6026 of 5 stars
$11.26
+0.9%
$15.20
+35.0%
+13.5%$3.20B$1.10B45.043,000Earnings Report
News Coverage
WGS
GeneDx
2.8804 of 5 stars
$112.49
+1.3%
$72.33
-35.7%
+244.8%$3.16B$305.45M-57.391,200Earnings Report
Analyst Forecast
Insider Trade
News Coverage
Positive News
BTSG
BrightSpring Health Services
1.6264 of 5 stars
$17.31
+2.3%
$21.67
+25.2%
+88.7%$3.03B$11.27B-66.5835,000Earnings Report
News Coverage
Positive News
PRVA
Privia Health Group
4.0272 of 5 stars
$23.20
+0.1%
$27.14
+17.0%
+26.7%$2.81B$1.74B232.02810Upcoming Earnings
Insider Trade
Short Interest ↓
Positive News
CON
Concentra Group Holdings Parent
N/A$21.64
+1.8%
$28.50
+31.7%
N/A$2.76B$1.90B14.3311,000Upcoming Earnings
News Coverage
Positive News
LFST
LifeStance Health Group
1.4411 of 5 stars
$6.53
flat
$8.30
+27.1%
+4.1%$2.51B$1.25B-25.126,640Upcoming Earnings
Positive News

Related Companies and Tools


This page (NASDAQ:SGRY) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners